Neuropsychiatric outcomes before and after switching to dolutegravir-based therapy in an acute HIV cohort. [electronic resource]
Producer: 20210112Description: 1 p. digitalISSN:- 1742-6405
- Adult
- Data Analysis
- Drug Substitution -- adverse effects
- Female
- HIV Infections -- drug therapy
- HIV Integrase Inhibitors -- adverse effects
- HIV-1 -- drug effects
- Heterocyclic Compounds, 3-Ring -- adverse effects
- Humans
- Longitudinal Studies
- Male
- Mental Disorders -- etiology
- Mood Disorders -- etiology
- Oxazines -- adverse effects
- Piperazines -- adverse effects
- Prospective Studies
- Pyridones -- adverse effects
No physical items for this record
Publication Type: Journal Article; Observational Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
There are no comments on this title.
Log in to your account to post a comment.